Caffeine Citrate 20mg/mL (2%)
equiv. of 19.4mg caffeine/2mL
10 vials per Pack
Note : Available only on the Sch 5A Scheme to Hospitals or under the SAS Scheme to individual patients.
Caffeine Citrate is indicated for the short term treatment of apnea in premature infants between 28 and <33 weeks gestation.